指南与共识外周动脉疾病

全球血管指南基于首次血运重建策略预测结局的有效性

Validity of the Global Vascular Guidelines in Predicting Outcomes Based on First-Time Revascularization Strategy.
指南 / 共识 · Ann Vasc Surg · 2023-02-23

单中心回顾性研究纳入2010至2018年281例首次血运重建的慢性肢体威胁性缺血患者,评估与全球血管指南推荐策略一致性对5年结局的预测价值。一致组与非一致组的5年免于主要不良肢体事件和总生存无显著差异;开放组主要不良肢体事件风险低于腔内组(HR 0.39)。

要点

  • 与指南推荐策略一致组和非一致组的5年免于主要不良肢体事件及总生存无显著差异。
  • 开放组主要不良肢体事件风险低于腔内组(HR 0.39,95%CI 0.17-0.91,P=0.029)。
  • GLASS分期与结局无显著关联,但分期越重即刻技术失败率越高(1期2.1%、2期6.4%、3期11.7%,P=0.01)。

核心结论

  • 在本研究中,慢性肢体威胁性缺血的治疗结局未因是否与全球血管指南推荐策略一致而出现显著差异。
  • 腔内组与开放组的总生存无差异,但腔内组再干预率更高。
  • 全球血管指南是指导慢性肢体威胁性缺血患者管理的重要资源,但本研究中指南一致性和GLASS分期均未能区分以腔内优先策略治疗的复杂患者的结局。
  • 慢性肢体威胁性缺血患者的血运重建方式需综合考虑患者解剖与临床状态、医生技能经验及机构资源。

研究设计与样本

  • 单中心回顾性研究,纳入2010至2018年综合保肢项目中首次下肢血运重建的慢性肢体威胁性缺血患者281例。
  • 按与全球血管指南推荐策略的一致性(一致组 vs 非一致组)、GLASS分期I-III及腔内 vs 开放策略进行分层。
  • 主要结局为5年免于主要不良肢体事件(免于再干预或大截肢),次要结局包括5年总生存、免于大截肢、免于再干预及初始血运重建期间的即刻技术失败。
  • 采用Kaplan-Meier生存分析和Cox比例风险模型多因素分析。

主要发现

  • 281例首次血运重建中,251例(89.3%)为腔内,186例(66.2%)为一致组,平均临床随访3.02±2.40年。
  • 一致组内167例(89.8%)血运重建为腔内。
  • 一致组较非一致组的慢性肾脏病比例更高(60.8% vs 45.3%,P=0.02),WIfI足部感染分级更高(0.81±1.1 vs 0.56±0.80,P=0.03),WIfI分期更高(3.1±0.79 vs 2.8±1.2,P<0.01)。
  • Kaplan-Meier和多因素分析均显示一致组与非一致组的5年免于主要不良肢体事件及总生存无显著差异。
  • Kaplan-Meier分析显示非一致组免于大截肢率更高(83.9% vs 74.2%,P=0.025),但多因素分析无统计学显著差异(HR 0.49,95%CI 0.21-1.15,P=0.10)。

关键数值与推荐

  • 全球血管指南推荐基于GLASS和WIfI分类系统选择腔内或开放手术进行慢性肢体威胁性缺血的血运重建。
  • 主要结局5年免于主要不良肢体事件定义为免于再干预或大截肢。

临床怎么用

  • 作者认为全球血管指南是指导慢性肢体威胁性缺血患者管理的重要资源。
  • 作者认为本研究中指南一致性和GLASS分期均未能区分以腔内优先策略治疗的复杂患者的结局。
  • 作者认为慢性肢体威胁性缺血患者的血运重建方式需综合考虑患者解剖与临床状态、医生技能经验及机构资源。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Global Vascular Guidelines (GVG) recommend selecting an endovascular versus open-surgical approach to revascularization for chronic limb-threatening ischemia (CLTI), based on the Global Limb Anatomic Staging System (GLASS) and wound, ischemia, and foot infection (WIfI) classification systems. We assessed the utility of GVG-recommended strategies in predicting clinical outcomes. METHODS: We conducted a single-center, retrospective review of first-time lower-extremity revascularizations within a comprehensive limb-preservation program from 2010 to 2018. Procedures were stratified by (1) treatment concordance with GVG-recommended strategy (concordant versus nonconcordant groups), (2) GLASS stages I-III, and (3) endovascular versus open strategies. The primary outcome was 5-year freedom from major adverse limb events (FF-MALE), defined as freedom from reintervention or major amputation, and secondary outcomes included 5-year overall survival, freedom from major amputation, freedom from reintervention, and immediate technical failure (ITF) during initial revascularization. Kaplan-Meier (KM) survival analysis and multivariate analysis with Cox proportional hazard models were performed on the primary and secondary outcomes. RESULTS: Of 281 first-time revascularizations for CLTI, 251 (89.3%) were endovascular and 186 (66.2%) were in the concordant group, with a mean clinical follow-up of 3.02 ± 2.40 years. Within the concordant group alone, 167 (89.8%) of revascularizations were endovascular. The concordant group had a higher rate of chronic kidney disease (60.8% vs. 45.3%, P = 0.02), WIfI foot infection grade (0.81 ± 1.1 vs. 0.56 ± 0.80, P = 0.03), and WIfI stage (3.1 ± 0.79 vs. 2.8 ± 1.2, P < 0.01) compared to the non-concordant group. After both KM and multivariate analyses, there were no significant differences in 5-year FF-MALE or overall survival between concordant and non-concordant groups. There was higher freedom from major amputation in the non-concordant group on KM analysis (83.9% vs. 74.2%, P = 0.025), though this difference was non-significant on multivariate analysis (hazard ratio [HR]: 0.49, 95% confidence interval [CI]: 0.21-1.15, P = 0.10). The open group had lower MALE compared to the endovascular group (HR: 0.39, 95% CI: 0.17-0.91, P = 0.029) attributed to a lower reintervention rate in the open group (HR: 0.31, 95% CI: 0.11-0.87, P = 0.026). GLASS stage was not associated with significant differences in outcomes, but the severity of GLASS stage was associated with ITF (2.1% in stage 1, 6.4% in stage 2, and 11.7% in stage 3, P = 0.01). CONCLUSIONS: In this study, CLTI treatment outcomes did not differ significantly based on whether treatment was received in concordance with GVG-recommended strategy. There was no difference in overall survival between the endovascular and open groups, though there was a higher reintervention rate in the endovascular group. The GVG guidelines are an important resource to help guide the management of CLTI patients. However, in this study, both concordance with GVG guidelines and GLASS staging were found to be indeterminate in differentiating outcomes between complex CLTI patients treated primarily with an endovascular-first approach. The revascularization approach for a CLTI patient is a nuanced decision that must take into account patient anatomy and clinical status, as well as physician skill and experience and institutional resources.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lou V, Dossabhoy SS, Tran K, et al. Validity of the Global Vascular Guidelines in Predicting Outcomes Based on First-Time Revascularization Strategy. Ann Vasc Surg. 2023. PMID: 36828135. doi:10.1016/j.avsg.2023.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。